Home/The Investor Series/Episode 05
Episode 05 The Investor Series
Nicholas Gnan on backing pre seed founders in preventive health
Nicholas Gnan of Peers Capital, a venture capital syndicate backing pre seed and seed companies in preventive health, on what is in scope, ticket sizes from 100K, why the team decides the deal and why preventive health is a long term market.
The mandate
Preventive health, from the shelf to the wrist
Peers Capital is a venture capital syndicate run by four leads who all operated businesses in preventive health. It backs anything that makes a positive impact on how people live, from better for you consumer goods to wearables, health apps, health data and longevity tech, across Europe and the US and, more and more, the Middle East. Pharma and biotech are out.
into Series A
ticket
range
former operators
The idea is most likely going to change in the next year or two. Will this person be durable?Nicholas Gnan, Peers Capital
Key takeaways
How Peers Capital decides
What is in scope, how tickets are sized, and why the team carries the decision.
A clear line on scope
Anything that makes a positive impact on how you live and helps people lead a healthier lifestyle is in, from consumer goods to longevity tech. The one part of the health ecosystem Peers will not cover is pharma and biotech.
Tickets from 100K, with room to grow
Tickets usually run from 100K to 500K and never go below 100K. Because family offices, ultra high net worth investors and angels sit behind the syndicate, an allocation can grow well beyond that depending on who takes the deal.
The team decides the deal
Most companies Peers sees are pre revenue, and the idea will probably change in the next year or two. So the question is whether the founder will be durable: roll with the punches, pivot when it makes sense, avoid shiny object syndrome and stay obsessed with the problem.
Show that you tried to de risk it
Even at idea stage, Peers wants to see the founder test demand, as simple as a landing page and a look at the conversions. A missing technical founder is a growing red flag: you can prototype with AI, but a health product has to be robust and secure.
Peers plans to build a fund alongside the syndicate, using the fund for faster deployment and larger allocations and the syndicate as a sidecar. Nicholas sees preventive health as a long term market: it is the one thing people value more the older and wealthier they get, and densely populated, high spending markets such as the GCC are well suited to proving new health models before they roll out.
Start a conversation
Better access to GCC capital starts with one call.
Every conversation in this series adds to the investor relationships we bring to our clients, from North American family offices to sovereign and private capital in the GCC. If you are raising, we will tell you which investors fit your company.
Book a call